HomeNATCOPHARM • NSE
add
Natco Pharma Ltd
Previous close
₹949.25
Day range
₹928.20 - ₹945.95
Year range
₹726.80 - ₹1,505.00
Market cap
167.41B INR
Avg Volume
2.17M
P/E ratio
10.88
Dividend yield
0.53%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.63B | -0.59% |
Operating expense | 6.66B | 53.22% |
Net income | 5.18B | -23.46% |
Net profit margin | 38.03 | -23.02% |
Earnings per share | 28.94 | -23.46% |
EBITDA | 5.82B | -27.59% |
Effective tax rate | 15.61% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.04B | 30.08% |
Total assets | 104.30B | 26.51% |
Total liabilities | 17.76B | 63.24% |
Total equity | 86.54B | — |
Shares outstanding | 179.13M | — |
Price to book | 1.97 | — |
Return on assets | — | — |
Return on capital | 15.67% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 5.18B | -23.46% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,199
